Objective: Surgical treatment in epilepsy is effective if the epileptogenic zone (EZ) can be correctly localized and characterized. Here we use simultaneous electroencephalography-functional magnetic resonance imaging (EEG-fMRI) data to derive EEG-fMRI and electrical source imaging (ESI) maps. Their yield and their individual and combined ability to (1) localize the EZ and (2) predict seizure outcome were then evaluated. Methods: Fifty-three children with drug-resistant epilepsy underwent EEG-fMRI. Interictal discharges were mapped using both EEG-fMRI hemodynamic responses and ESI. A single localization was derived from each individual test (EEG-fMRI global maxima [GM]/ESI maximum) and from the combination of both maps (EEG-fMRI/ESI spatial intersection). To determine the localization accuracy and its predictive performance, the individual and combined test localizations were compared to the presumed EZ and to the postsurgical outcome. Results: Fifty-two of 53 patients had significant maps: 47 of 53 for EEG-fMRI, 44 of 53 for ESI, and 34 of 53 for both. The EZ was well characterized in 29 patients; 26 had an EEG-fMRI GM localization that was correct in 11, 22 patients had ESI localization that was correct in 17, and 12 patients had combined EEG-fMRI and ESI that was correct in 11. Seizure outcome following resection was correctly predicted by EEG-fMRI GM in 8 of 20 patients, and by the ESI maximum in 13 of 16. The combined EEG-fMRI/ESI region entirely predicted outcome in 9 of 9 patients, including 3 with no lesion visible on MRI. Interpretation: EEG-fMRI combined with ESI provides a simple unbiased localization that may predict surgery better than each individual test, including in MRI-negative patients.
without a magnetic resonance imaging (MRI)-visible lesion. Electroencephalography (EEG)-functional MRI (fMRI) and electrical source imaging (ESI) are both good candidates, but definitive studies are needed to determine their diagnostic performance in the pediatric population.
Previous EEG-fMRI studies in adults have shown that fMRI can map the EZ using interictal 2, 3 and ictal 4 events. Compared to clinical EEG alone, EEG-fMRI has been shown to provide a more accurate localization of the EZ in up to two thirds of cases, 5 to have a good degree of correlation with invasive EEG findings, 6 and to be predictive of good surgical outcome. 7, 8 However,
EEG-fMRI maps often show multiple regions of activity that, although consistent with the idea that epilepsy is a network disease, 6, [9] [10] [11] [12] complicate interpretation where a single spatial target is typically required for surgery to proceed. Previous studies have often used the statistic global maxima (GM), 8, 13 or have constrained the search area to the spike field 5 or to the clinically defined epileptic focus 2, 3 to obtain a localization. Unfortunately, these approaches can have low sensitivity (in the case of GM) or are dependent on subjective interpretation if they use a clinically defined focus or are based on the interictal epileptiform discharge (IED) field. Furthermore, in a pediatric cohort, clinical EEG is often less localizing and repeat surgery relatively common, and therefore the use of IED fields may be problematic. Recently, EEG-fMRI was shown to be feasible in children from 6 to 18 years old without sedation and to possibly have a higher yield compared with adults in a selected population. 14 Additionally, new methodological developments (topographic voltage correlation analysis) 15 allow EEG-fMRI maps to be obtained without IEDs. ESI has been shown to localize the EZ with high sensitivity and specificity in a mixed group of adults and children using high-density (>32 channel) EEG 16 and has shown promise in a pediatric cohort. 17 ESI has a limited spatial accuracy and can have limitations in cases with deep sources 18 , previous surgery, 19 or where IEDs are not typical discrete events. Studies have investigated the spatial consistency of EEG-fMRI and ESI maps 20, 21 and their localization performance, 22 but they have not been combined to improve their potential predictive value.
Here, high-density EEG-fMRI data were used to derive ESI and EEG-fMRI maps. We aimed to: (1) quantify the yield, (2) determine the localizing value, and (3) assess the predictive value of EEG-fMRI and ESI individually and as a combined test in the largest pediatric focal epilepsy population studied to date with either method.
Patients and Methods

Subjects
Fifty-three children with drug-resistant epilepsy underwent simultaneous EEG-fMRI. At the point of recruitment, the children were undergoing evaluation for resective epilepsy surgery at Great Ormond Street Hospital for Children (London, United Kingdom). The patients were recruited prospectively between November 2011 and May 2015; inclusion criteria for the study were the presence of frequent interictal discharges and the capacity to undergo an MRI without sedation.
The clinical data of the 53 patients are summarized in Supplementary Table 1 . Thirty patients had a structural lesion on MRI (56%) and 23 (44%) were lesion negative.
PATIENT GROUP FOR YIELD ASSESSMENT. All 53 patients were included in the calculation of test yield.
PATIENT GROUP FOR LOCALIZATION VALUE ASSESSMENT.
All patients underwent video-telemetry-EEG to document seizures and structural MRI for presurgical assessment. In 29 of 53 patients, the EZ was considered well-localized based on the following criteria: (1) MRI lesion concordant with the electroclinical data (15 patients) or (2) good outcome following surgery (14 patients; 12 lesional/2 nonlesional). Patients with poor outcome or without an MRI lesion (unless they had good surgical outcome) were excluded from this group, because their EZ was not well localized. The volume of the EZ was estimated, and these values are included in Supplementary Table 1. PATIENT GROUP FOR PREDICTION OF SURGICAL OUT-COME ASSESSMENT. All 20 patients within the study who underwent resective surgery were included. Five of 20 had no visible lesion in the MRI. Surgical outcome for each patient was classified according to the modified International League against Epilepsy (ILAE) classification system 23 before being further divided into good or poor outcome based on the surgical goal being met. Good outcomes were therefore considered to be ILAE class 1 and 2. In 3 patients with large lesions (involving > 1 lobe), a partial resection of the lesion was chosen to spare eloquent cortex. In these patients, if a significant seizure reduction of >50% was achieved (ILAE class 4), the outcome was considered to be favorable, as this was the a priori surgical aim. For all other categories outcome was considered to be poor. The relative brain volume that was resected was estimated, and these values are included in Supplementary Table 1 .
EEG-fMRI Acquisition
Full scanning protocol details are described in our previous work. 14 Patients were prepared with a 64-electrode MRI-compatible EEG cap (Easy Cap; Brain Products, Gilching, Germany). All patients underwent between 2 and 4 EEG-fMRI sessions lasting 10 minutes each (300 volumes, repetition time-5 2.16 seconds) and a T1-weighted whole-brain structural image. To maintain consistency across subjects, only the first 2 sessions (20 minutes) of EEG-fMRI were used in the analysis, with the added benefit of reduced subject movement without affecting blood oxygen level-dependent contrast imaging (BOLD) results. 14 In 2 patients in whom seizures with movement occurred during the first 2 sessions, the subsequent sessions free of seizures were analyzed. Preprocessing of EEG and identification/classification of IEDs on EEG traces were carried out as described previously in Centeno et al. 14 In summary, IEDs for each subject were classified as a separate IED type according to the topographical distribution of the activity. 13 
EEG-fMRI Analysis
IED CORRELATION ANALYSIS. A mass univariate fMRI analysis was performed using SPM8 version r5232 (http://www. fil.ion.ucl.ac.uk/spm/) running in MATLAB (MathWorks, Natick, MA). Preprocessing consisted of image realignment (SPM8) followed by the removal of nonphysiological signal changes using FIACH. 24 Slice time correction and smoothing with an 8mm
kernel were subsequently applied (SPM8). A general linear model was generated for each subject where for each IED type, IED onset (and duration in the case of IED runs) was convolved with the canonical hemodynamic response function (HRF) and its time and dispersion derivatives. Motion realignment parameters and FIACH physiological noise regressors 14, 24 were entered as effects of no interest. Brain regions with signal changes associated with each IED type were tested with an F test across the 3 IED regressors (HRF and the 2 derivatives) to account for variability in the hemodynamic response shape. 25, 26 A more detailed explanation of the model used can be found in Centeno et al.
14
TOPOGRAPHIC IED VOLTAGE MAP CORRELATION. In those patients in whom IED were not captured during the EEG-fMRI sessions, a regression analysis of the typical IED topographic voltage maps was applied to the EEG-fMRI data following the procedure described by Grouiller et al. 15 In brief, a patient's IED topography derived from their clinical EEG is spatially correlated with the topography of the EEG obtained inside the scanner at each time point. The fMRI signal changes associated with an increased correlation to the IED topography are obtained, which can reflect the generators of focal epileptic activity. 27, 28 Changes in BOLD fMRI signal were considered significant at an individual level of p < 0.001 (uncorrected), with a voxel cluster having a minimum of 5 contiguous voxels.
14 This threshold is arbitrary but was chosen a priori to strike an appropriate balance between sensitivity and specificity based on the range of design efficiency that is encountered among patients. This threshold was applied to both IED-related and topographic correlation analysis maps.
ESI
Only patients with IEDs captured during the EEG-fMRI sessions (using a 64-electrode cap) had ESI analysis. We calculated the ESI of each IED type identified on the EEG using Cartool software (https://sites.google.com/site/fbmlab/cartool) and followed the procedure described in Vulliemoz et al.
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FIGURE 1: Localization extraction procedure. From left to right: electroencephalography-functional magnetic resonance imaging (EEG-fMRI) data are used to obtain a map for EEG-fMRI and electrical source imaging (ESI). For each of these individual maps, a single localization is selected; for the EEG-fMRI the global maxima is selected, and for the ESI the maximum in the map from the 50% rising phase of the interictal epileptiform discharge is selected as the localization. For the combined test, the localization is derived from the spatial conjunction of both maps. Where the maps are concordant, the localization is the region encompassing the ESI maximum and the closest significant EEG-fMRI cluster located in the same sublobe. When the maps are discordant cases, no combined localization is extracted. [Color figure can be viewed at wileyonlinelibrary.com]
Localization Derived from EEG-fMRI and ESI Individually and Combined
A single localization was derived from each EEG-fMRI and ESI map used individually, and subsequently a combined localization was derived (Fig 1) .
INDIVIDUAL TEST LOCALIZATION.
The single localization obtained from EEG-fMRI maps was the cluster containing the statistical global maxima. The single localization from the ESI maps was the ESI maximum solution point for the map corresponding to the 50% rising phase of the IED.
COMBINED EEG-FMRI/ESI LOCALIZATION. To obtain a single localization from the combination of EEG-fMRI and ESI, both maps were coregistered and overlaid on the subject's structural T1-weighted image. Combined EEG-fMRI/ESI localization was extracted in those cases in which ESI maximum and an EEG-fMRI cluster were localized to the same sublobar region. Sublobar regions were defined as follows 30 : frontal polar, dorsal lateral frontal, mesial frontal, lateral parietal, mesial parietal, lateral occipital, mesial occipital, lateral temporal, temporal polar, and mesial temporal. The location derived from the combined EEG-fMRI and ESI maps was defined as the region that comprised both the ESI maximum and the nearest EEG-fMRI cluster within the same sublobe. Additionally, the Euclidian distance between the ESI maximum and EEG-fMRI cluster located in the same sublobe was calculated for the combined EEG-fMRI/ESI cases.
Assessment of the Value of the EEG-fMRI and ESI
TEST YIELD. To determine the ability of the test to provide a localization result, the "test yield" was calculated and is given by the number of patients with a test localization result divided by the total number who received the test.
LOCALIZATION ACCURACY. Here, we aimed to address the question, "Given a test localization result, what is the probability that it is correct?" To do this, the patient group with a welllocalized EZ (n 5 29 see above) was used (Fig 2) . When the test resulted in a localization and it fell within the EZ, it was classed as a true positive (a correct localization); otherwise, if the test resulted in a localization and it did not fall within the (2) calculating the prediction accuracy for seizure outcome in all patients who underwent surgery (bottom row). Here a TP was a localization within the resection margins and good outcome; an FP was a localization within the resection margins and poor outcome; true negative (TN) and false negative (FN) were a localization that was not within the resection margins and a poor or good outcome, respectively. [Color figure can be viewed at wileyonlinelibrary.com] EZ, it was considered a false positive (an incorrect localization). This was repeated for the individual localization results from ESI and EEG-fMRI and for the combined localization. Note that where the test does not provide a localization, the test cannot be categorized as providing true or false, positive or negative localization information (the absence of evidence cannot be taken as evidence of absence).
SURGERY OUTCOME PREDICTION. Third, we aimed to assess the ability of EEG-fMRI and ESI localization to predict seizure outcome (see Fig 2) . In patients who underwent surgery, we defined a true positive as being when the localization provided by the test was resected with a good outcome, and false positive as when the localization provided by the test was resected followed by a poor outcome. True and false negatives were defined as the localization provided by the test not being resected and the outcome being poor and good, respectively. 8 True positives and true negatives were considered correct predictions (prediction successes); otherwise, the prediction was incorrect (prediction failures).
Statistical Analysis and Confidence Estimates
Binomial calculations are often used to quantify uncertainty in diagnostic test sensitivities using confidence intervals. However, these intervals are inaccurate if percentages approach 100%. We therefore adopted a Bayesian approach to estimating the sensitivity and the associated uncertainty. The prior information we incorporate is in the form of a beta distribution, which is the typical prior distribution for proportions. 31 The beta distribution has 2 parameters, a and b, both of which have a meaningful clinical interpretation. For EZ localization, the parameter a is simply the number of times a given test correctly localized the EZ, whereas the b parameter is the number of times the test incorrectly localized the EZ. For surgical prediction, a is the number of successful predictions (true positives plus true negatives), whereas b is the number of failures (false positives plus false negatives). The values for a and b for the prior distribution can incorporate information from previous studies. When none is available, the starting assumption is that a and b are equally likely and so a 5 b 5 1 (in this special case the prior distribution is a uniform distribution also called a flat prior). For EEG-fMRI GM, we incorporated information from 2 studies. 8, 13 The resulting prior for EEG-fMRI GM sensitivity (h) was h Beta(14,10). For ESI, we used the study by Brodbeck et al. 16 The resulting prior for ESI is h Beta(45,9). In the absence of data for the combined method, the prior remained uninformative: h Beta(1,1). This prior remained the same for the localization sensitivity and the prediction of surgical outcome. These priors were then used together with our data to describe the posterior distribution of sensitivity in the population. The uncertainty was then simply characterized using a 95% credible interval calculated using the 0.975 and 0.025 quantiles of the posterior distribution. The chance level of localization was based on the estimated EZ volume or resection volume (see Supplementary   Table 1 ). The distribution of this variable was unknown a priori. To calculate the mean chance level of localization and associated measures of uncertainty, we therefore used a bootstrap procedure. This was implemented in the boot package of the R programming language. 32, 33 The number of bootstrap replicates was 5,000. Credible intervals were calculated using the 0.975 and 0.025 quantiles of the resulting distribution of the mean. The sensitivity of a given test lies within the credible interval with 95% probability and is therefore considered here to be significantly improved (relative to chance levels or other tests) when the 95% intervals did not overlap.
Results
Forty-four of 53 patients (83%) had IEDs during EEGfMRI sessions. The number of IED types per patient ranged from 1 to 4 (mean 5 1.6). Twenty-four patients (54%) had 1 IED type; 14 patients (31%) had 2 types of IED, 5 patients (11%) had 3 types of IED, and 1 patient (2%) had 4 types of IED (Supplementary Table  2 ). The results are summarized in the Table. Test Yield In summary, 52 of 53 patients (98%) had a significant result for at least 1 of the tests. Forty-seven of 53 patients had significant clusters of activity on the EEG-fMRI maps (88% test yield). Thirty-nine of the EEG-fMRI maps were IED-related, and 8 were topographic voltage correlation maps (8 of 9 patients without IEDs). The EEG-fMRI maps contained > 1 cluster in 46 of 47 patients.
ESI was obtained in 39 of 53 patients (73% test yield). In 14 patients, ESI could not be obtained for the following reasons: no IED (9 patients), IED were rhythmic irregular bursts (1 patient), EEG artifact (1 patient), structural MRI preprocessing problems (3 patients).
The combined ESI/EEG-fMRI gave a single localization in 23 of 53 patients (43% test yield). In 11 of 23 patients, the EEG-fMRI cluster that was concordant with ESI was the GM. The mean distance between EEGfMRI cluster and ESI maximum was 14.6mm, ranging from 5 to 30mm for the combined EEG-fMRI/ESI localisation. A summary of test yield for MRI-negative and lesional patients is shown in Figure 3 . Details of individual subjects' localization derived from EEG-fMRI/ ESI used individually and combined can be found in Supplementary Table 2 .
Localization Accuracy Twenty-six of the 29 patients with a well-characterized EZ had significant BOLD changes on EEG-fMRI maps; 11 of 26 correctly localized the EZ with the GM. Twentytwo patients of the 29 had an ESI map; in 17 of 22, the maximum correctly localized the EZ. Twelve of the 29 had a combined localization from EEG-fMRI and ESI maps; 11 of 12 correctly localized the EZ (see Table) . The localization performance of all tests was above chance levels. Both ESI and the combined test were better at localizing than the EEG-fMRI GM method based on the criteria of nonoverlapping 95% intervals (see Table) .
Surgical Prediction Accuracy
Twenty patients underwent surgery and had postoperative outcome (mean 5 29 months, range 5 10-57 months). Eleven patients (55%) were seizure free. Nine patients continued having seizures after surgery and were classified as ILAE class 2 (1 patient), class 4 (3 patients), and class 5 (5 patients; see Supplementary Table 1) . Two of the patients underwent a partial resection of a large lesion, with the aim of significantly reducing the seizure burden but not necessarily achieving seizure freedom. These patients (#28 and #39) had an outcome ILAE of 4, with a reduction of >50%, and so were additionally considered as having a good outcome based on the different aim of the surgery. Therefore, the total number of patients with good outcome was 14 out of 20. Five patients in the surgical group were MRI negative (#2, #7, #25, #44, #50). Four of these had both EEG-fMRI and ESI maps, with 3 of them having a combined EEG-fMRI/ESI localization (#25, #44, #50).
Outcome was correctly predicted in 8 out of 20 patients by EEG-fMRI GM, in 13 out of 16 by ESI, and in 9 out of 9 by combined EEG-fMRI and ESI. The predictive performance of all tests was above chance level, and both ESI and the combined test were better at localizing than the EEG-fMRI GM based on the criteria of nonoverlapping 95% intervals (see Table) . Current study summary TP 5 Test yield is calculated as the number of subjects in whom a significant map was obtained. Localization accuracy was calculated in those patients with a well-localized epileptogenic zone, and surgical prediction in those patients who underwent surgical resection. No. represents the number of subjects for whom the test provided a result. The current study summary row gives the number of true positives (TP), false positives (FP), true negatives (TN), and false negatives (FN). The test sensitivity is, given a result, the likelihood that it was correct; a and b are the hyperparameters of the beta distribution. Prior hyperparameters are based on the results of previous studies where available or are set to both equal 1 where there is no prior information. CI 5 confidence interval EEG 5 electroencephalography; ESI 5 electrical source imaging; fMRI 5 functional magnetic resonance imaging; GM 5 global maxima.
Discussion
In this study, we retrospectively evaluated the potential localizing and predictive value of EEG-fMRI and ESI individually and when used as a combined test in the largest pediatric focal epilepsy population studied to date with either method. The yield of EEG-fMRI alone was 89%, ESI alone 73%, and combined EEG-fMRI/ESI 43%. Low yield has been highlighted as a limiting factor for the clinical use of EEG-fMRI. Studies report significant findings in 27 to 76% of cases. 2, 5, 13 The improvement in the yield in our study may be explained by the population of pediatric patients studied, who typically have frequent IEDs, and the use of topographic correlation analysis (which allowed a localization to be achieved in the cases without IEDs). All tests were more accurate than chance levels of correct localization (see Table) . Both combined ESI/ EEG-fMRI (92%) and ESI (82%) were more accurate than the EEG-fMRI GM localization (50%). The results for surgical outcome prediction were consistent with the localization results. All tests were significantly more predictive than chance levels. Both combined ESI/EEGfMRI (91%) and ESI (83%) were more accurate than the EEG-fMRI GM localization (50%). Importantly, this surgical group of 20 included 5 patients without an MRI lesion. ESI obtained a localization in 4 out of 5, and in all patients it was predictive of outcome. Combined EEG-fMRI/ESI obtained a localization in 3 out of 5, and in all patients it was predictive of outcome.
Comparison with Previous Studies
Previous studies have shown the potential of EEG-fMRI maps to localize and contribute to EZ characterization. 2, 5, 8, 13 However, the localization accuracy of EEGfMRI remains poorly characterized in the literature.
EEG-fMRI maps often show a multifocal pattern of significant responses, and this has led to different ways of extracting a single localization from an EEG-fMRI map.
The statistic GM has often been used as the marker of the cluster likely to represent the EZ. 5, 8 Although the GM is an unbiased and easy method to extract a single location from a multifocal EEG-fMRI map, it suffers from poor sensitivity because it is often located in regions remote from the EZ. In a recent study, 8 the EEG-fMRI GM was shown to have a sensitivity of 45% to localize the EZ, which is in line with our findings. The meaning and clinical significance of the often multifocal EEG-fMRI maps of interictal epileptiform activity remain unclear, which is closely related to the problem of defining the test's localization result. In this study, we proposed an alternative and unbiased method to extract a single location from EEG-fMRI data by incorporating the IED information through ESI maps and assessing the concordance between them. This method relies exclusively on imaging information, avoiding the interpretation bias of viewing EEG-fMRI and ESI maps in light of clinical information. However, despite being very accurate, the yield of combined ESI and EEG-fMRI was modest (23 of 53) compared to EEG-fMRI (47 of 53) in our patient group. Given the high yield but low accuracy of EEG-fMRI GM to define the EZ, the clinical utility of EEG-fMRI could potentially be dramatically improved by epileptic network characterization methods that can define the EZ and regions of propagation directly from EEG-fMRI data. 29 Studies focused on comparing these results with epileptiform activity measured invasively, including with simultaneously acquired fMRI, 34, 35 may help resolve this issue.
EEG-fMRI clusters of activity and ESI maps have both been shown to have a good spatial consistency with the intracranial EEG findings, but they do not completely overlap. 20 Bagshaw et al 36 reported a mean distance of 60mm between the ESI and EEG-fMRI activity clusters obtained in separate sessions. In our data, we found an average distance of 14mm, with a range of 5 to 30mm in the cases where a concordant localization was found with EEG-fMRI and ESI. These distances and the concordance between ESI and EEG-fMRI GM are consistent with a previous study in adults. 29 This difference could suggest that each technique is more sensitive to different regions involved in the IED and may contribute to a better characterization of EZ than each map alone. However, EEG source localization is typically considered to have a spatial accuracy on the order of 1cm, and there are likely to be differences in the location of the maximum of regional electrical and hemodynamic responses, the latter being sensitive to the local vascular architecture. These methodological considerations could easily account for the average difference in localization of 14mm found here. There are a number of methodological choices that could influence the accuracy of the ESI results. A greater EEG density (above the 64 channels used here) may improve the spatial accuracy of ESI. 16, 36 We used a spherical head model with anatomical constraints based on a 3-shell spherical realistic head model and the patient's individual MRI spherical head model; this is an active area of research and more advanced and specific models may also improve accuracy. 37 These methodological choices were motivated by our desire to make a comparison to the largest study of the application of ESI to presurgical epilepsy evaluation in the literature, 16 ,37 and so we therefore followed the same approach. ESI was shown to accurately map the generators of IEDs from data obtained during an EEG-fMRI recording in our pediatric population, providing useful predictive information for the presurgical assessment. The sensitivity of ESI alone to localize the EZ was 82%, which replicates the results in a previous study, which examined a mixed cohort of adults and children using EEG data from outside the scanner. 16 ESI is therefore a technique that can provide a relatively low-cost minimally invasive test with high accuracy in the context of evaluation for pediatric epilepsy surgery. However, its accuracy may be more limited in some cases, such as those with deep sources, or in patients with brain and skull abnormalities. In our sample, there were 6 cases in which ESI was inconsistent with the MRI lesion. Four of them were patients with deep lesions, and 1 patient had undergone previous surgery. To determine test sensitivity and reliability, we used a Bayesian approach. This allowed the incorporation of prior information (where available) to increase the confidence in our results. For ESI and EEG-fMRI GM, the priors on the sensitivity were very consistent with the data from the current study, and therefore their incorporation had little effect on the sensitivity but reduced the credible interval (crucially allowing for more accurate population level inference). For combined EEG-fMRI/ ESI, the uninformative prior reduces the sensitivity estimate (reflecting our uncertainty in this novel methodology due to low numbers). Using this approach, future studies can readily update these numbers to further refine these sensitivity estimates by using our posterior distributions as priors in their work.
Clinical Value
The aim of presurgical evaluation is to identify a clear hypothesis for the EZ that can be confirmed by intracranial recording or allows for surgery to be offered with an appropriate understanding of risk-benefit. In patients who have an MRI lesion consistent with electroclinical information, this is often achieved. However, for patients without an MRI lesion, it becomes difficult to formulate a spatially constrained hypothesis. Positron emission tomography (PET) and single photon emission computed tomography (SPECT) can be used to formulate a spatial hypothesis 38 ; however, the spatial accuracy of these techniques is poor. In this study, we have shown that a combined EEG-fMRI and ESI result from a single dataset is highly localizing and predictive of surgical outcome with or without an MRI lesion. Furthermore, the localization provided by these tests (typically at the sublobar level) is more spatially accurate than most of the current noninvasive presurgical tests (EEG, PET, and SPECT) that are used to localize the EZ in patients with no MRI lesion.
Limitations
This study is limited by the numbers in the subgroup of patients in whom the validation of the localization results could be carried out (29 of 53). This represents a potential (but unavoidable) bias, because the patients in whom an EZ is well characterized may not fully represent the sample. We included a group of 23 MRI-negative patients who have a poorer likelihood of having a welldefined EZ and therefore are much less likely to undergo surgery. This choice was necessitated by the need for an assessment of the accuracy of the localization tests in this group. A combined EEG-fMRI/ESI localization was found in 12 out of 23 MRI-negative patients, and outcome was predicted in all 3 who had surgery. Our results therefore strongly motivate a larger study of combined EEG-fMRI and ESI in MRI-negative patients with validation based on intracranial EEG or surgery.
Patients with a well-defined cortical MRI abnormality concordant with electroclinical information are unlikely to benefit from EEG-fMRI, given its cost. In these cases, based on our data, ESI represents an additional relatively low-cost test with good sensitivity in children with frequent IEDs. However, patients without an MRI-visible abnormality, a deep-lying or extensive MRI abnormality, and/or prior surgery are likely to benefit from combined EEG-fMRI and ESI.
